Oscar Segurado

Oscar Segurado

Company: ASC Therapeutics

Job title: Chief Medical Officer


In Vivo Gene Editing to Treat Monogenic Blood Disorders 9:00 am

• Moving from traditional gene therapy to in vivo gene editing approaches • Combining CRISPR/Cas9 with second generation factor VIII transgene • Targeting the liver to treat hemophilia and beta-thalassemiaRead more

day: Day Two

© Copyright 2022 Hanson Wade | Design and site by Event Engine | Hanson Wade Limited is registered in England & Wales, number 06752216.
Registered Office: Suite A, 6 Honduras Street, London EC1Y 0TH.